Caisse de Depot et Placement du Quebec (CDPQ)’s Alexion Pharmaceuticals ALXN Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-53,525	Closed	-$9.83M	–	557
2021 Q2	$9.83M	Sell	53,525 -17,100	-24%	-$2.94M	0.02%	263
2021 Q1	$10.8M	Buy	70,625 +68,973	+4,175%	+$10.7M	0.02%	213
2020 Q4	$258K	Sell	1,652 -3,072	-65%	-$395K	﹤0.01%	664
2020 Q3	$541K	Sell	4,724 -1,900	-29%	-$205K	﹤0.01%	614
2020 Q2	$743K	Sell	6,624 -31,000	-82%	-$3.29M	﹤0.01%	584
2020 Q1	$3.38M	Buy	37,624 +9,800	+35%	+$962K	0.01%	321
2019 Q4	$3.01M	Buy	27,824 +20,300	+270%	+$2.17M	0.01%	377
2019 Q3	$737K	Sell	7,524 -22,000	-75%	-$2.48M	﹤0.01%	730
2019 Q2	$3.87M	Buy	29,524 +18,000	+156%	+$2.32M	0.01%	355
2019 Q1	$1.56M	Buy	11,524 +4,400	+62%	+$547K	﹤0.01%	538
2018 Q4	$694K	Sell	7,124 -24,684	-78%	-$2.92M	﹤0.01%	651
2018 Q3	$4.42M	Buy	31,808 +25,226	+383%	+$3.16M	0.01%	371
2018 Q2	$817K	Sell	6,582 -90	-1%	-$10.5K	﹤0.01%	654
2018 Q1	$744K	Sell	6,672 -23,682	-78%	-$2.83M	﹤0.01%	640
2017 Q4	$3.63M	Sell	30,354 -10,070	-25%	-$1.23M	0.01%	412
2017 Q3	$5.7M	Buy	40,424 +800	+2%	+$109K	0.01%	316
2017 Q2	$4.81M	Buy	39,624 +5,900	+17%	+$687K	0.01%	331
2017 Q1	$4.09M	Buy	33,724 +23,600	+233%	+$3.04M	0.01%	353
2016 Q4	$1.24M	Sell	10,124 -27,800	-73%	-$3.4M	﹤0.01%	581
2016 Q3	$4.65M	Sell	37,924 -2,500	-6%	-$322K	0.01%	358
2016 Q2	$4.72M	Buy	40,424 +26,100	+182%	+$3.7M	0.01%	433
2016 Q1	$1.99M	Sell	14,324 -81,476	-85%	-$12M	0.01%	607
2015 Q4	$18.3M	Sell	95,800 -4,100	-4%	-$716K	0.05%	172
2015 Q3	$15.6M	Buy	99,900 +1,600	+2%	+$292K	0.04%	197
2015 Q2	$17.8M	Buy	98,300 +9,100	+10%	+$1.57M	0.05%	194
2015 Q1	$15.5M	Sell	89,200 -7,000	-7%	-$1.27M	0.04%	212
2014 Q4	$17.8M	Sell	96,200 -8,400	-8%	-$1.56M	0.05%	190
2014 Q3	$17.3M	Sell	104,600 -3,600	-3%	-$591K	0.05%	212
2014 Q2	$16.9M	Sell	108,200 -5,300	-5%	-$837K	0.05%	222
2014 Q1	$17.3M	Buy	113,500 +3,080	+3%	+$490K	0.05%	211
2013 Q4	$14.7M	Sell	110,420 -15,200	-12%	-$1.82M	0.04%	247
2013 Q3	$14.6M	Sell	125,620 -23,600	-16%	-$2.59M	0.04%	281
2013 Q2	$13.8M	Buy	+149,220	New	+$14.4M	0.04%	313

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s ALXN Position: Q3 2021 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 53,525 shares — an estimated $9.83M sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $18.3M in Q4 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Caisse de Depot et Placement du Quebec (CDPQ) sold 53,525 Alexion Pharmaceuticals shares in Q3 2021, an estimated $9.83M.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
Caisse de Depot et Placement du Quebec (CDPQ)'s Alexion Pharmaceuticals position peaked at $18.3M in Q4 2015.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q3 2021, filed 12 Nov 2021.